Semnur Pharmaceuticals, Inc.
SMNR
$0.55
-$0.01-1.79%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 39.00K | 103.00K | 20.00K | 85.00K | 55.00K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.10M | 1.12M | 576.00K | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 51.00K | -- | -- | -- | 8.34M |
| Total Current Assets | 1.19M | 1.22M | 596.00K | 85.00K | 8.39M |
|
|
|||||
| Total Current Assets | 1.19M | 1.22M | 596.00K | 85.00K | 8.39M |
| Net Property, Plant & Equipment | 750.00K | 750.00K | 750.00K | 689.00K | 689.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1.94M | 1.97M | 1.35M | 774.00K | 9.08M |
|
|
|||||
| Total Accounts Payable | 6.92M | 6.42M | 5.91M | 4.29M | -- |
| Total Accrued Expenses | 1.65M | 1.19M | 739.00K | 1.27M | 1.33M |
| Short-term Debt | 2.11M | 2.77M | 3.52M | 4.48M | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 23.00K |
| Total Other Current Liabilities | -- | -- | -- | -- | 23.00K |
| Total Current Liabilities | 10.67M | 10.38M | 10.17M | 10.03M | 1.36M |
|
|
|||||
| Total Current Liabilities | 10.67M | 10.38M | 10.17M | 10.03M | 1.36M |
| Long-Term Debt | 20.94M | 16.92M | 11.93M | 5.34M | 52.17M |
| Short-term Debt | 2.11M | 2.77M | 3.52M | 4.48M | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 31.62M | 27.30M | 22.10M | 15.37M | 53.53M |
|
|
|||||
| Common Stock & APIC | 255.05M | 255.05M | 255.05M | 255.05M | 72.60M |
| Retained Earnings | -284.72M | -280.38M | -275.80M | -269.64M | -117.05M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -29.67M | -25.33M | -20.75M | -14.59M | -44.45M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 1.00K | 1.00K | 1.00K | 1.00K | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 1.00K | 1.00K | 1.00K | 1.00K | -- |
|
|
|||||
| Total Common Equity | -29.67M | -25.33M | -20.75M | -14.59M | -44.45M |
| Total Preferred Equity | 1.00K | 1.00K | 1.00K | 1.00K | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -29.67M | -25.33M | -20.75M | -14.59M | -44.45M |
|
|
|||||